ARHGDIA antibody
Quick Overview for ARHGDIA antibody (ABIN6989737)
Target
See all ARHGDIA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Human, Mouse, Rat
-
Purification
- Purified by Protein A.
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-204 of human ARHGDIA (NP_001172006.1).
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:300-5000
IF(ICC) 1:50-200
IF() -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C for 12 months.
-
Expiry Date
- 12 months
-
-
- ARHGDIA (rho GDP Dissociation Inhibitor (GDI) alpha (ARHGDIA))
-
Alternative Name
- ARHGDIA
-
Background
-
Synonyms: ARHGDIA,GDIA1,HEL-S-47e,NPHS8,RHOGDI,RHOGDI-1
Background: This gene encodes a protein that plays a key role in the regulation of signaling through Rho GTPases. The encoded protein inhibits the disassociation of Rho family members from GDP (guanine diphosphate), thereby maintaining these factors in an inactive state. Activity of this protein is important in a variety of cellular processes, and expression of this gene may be altered in tumors. Mutations in this gene have been found in individuals with nephrotic syndrome, type 8. Alternate splicing results in multiple transcript variants.
-
Gene ID
- 396
-
UniProt
- P52565
-
Pathways
- Neurotrophin Signaling Pathway
Target
-